Abstract
The neurovascular unit (NVU), composed of endothelial cells, pericytes, juxtaposed astrocytes and microglia together with neurons, is essential for proper central nervous system functioning. The NVU critically regulates blood–brain barrier (BBB) function, which is impaired in several neurological diseases and is therefore a key therapeutic target. To understand the extent and cellular source of BBB dysfunction, simultaneous isolation and analysis of NVU cells is needed. Here, we describe a protocol for the EPAM-ia method, which is based on flow cytometry for simultaneous isolation and analysis of endothelial cells, pericytes, astrocytes and microglia. This method is based on differential processing of NVU cell types using enzymes, mechanical homogenization and filtration specific for each cell type followed by combining them for immunostaining and fluorescence-activated cell sorting. The gating strategy encompasses cell-type-specific and exclusion markers for contaminating cells to isolate the major NVU cell types. This protocol takes ~6 h for two sets of one or two animals. The isolation part requires experience in animal handling, fresh tissue processing and immunolabeling for flow cytometry. Sorted NVU cells can be used for downstream applications including transcriptomics, proteomics and cell culture. Multiple cell-type analyses using UpSet can then be applied to obtain robust targets from single or multiple NVU cell types in neurological diseases associated with BBB dysfunction. The EPAM-ia method is also amenable to isolation of several other cell types, including cancer cells and immune cells. This protocol is applicable to healthy and pathological tissue from mouse and human sources and to several cell types compared with similar protocols.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
All the raw data and derived data of this manuscript are available from the corresponding author upon reasonable request. The transcriptomic datasets referred to in this manuscript have been uploaded to NCBI database GSE163752, and also to other servers (https://bioinformatics.mpi-bn.mpg.de/SGD_Stroke, http://vcg.github.io/upset/ followed by pasting the JSON file link https://raw.githubusercontent.com/SGD2020/mcao/master/mcao.json)
References
Liebner, S. et al. Functional morphology of the blood–brain barrier in health and disease. Acta Neuropathol. 135, 311–336 (2018).
Sweeney, M. D., Sagare, A. P. & Zlokovic, B. V. Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat. Rev. Neurol. 14, 133–150 (2018).
Banks, W. A. From blood–brain barrier to blood–brain interface: new opportunities for CNS drug delivery. Nat. Rev. Drug Discov. 15, 275–292 (2016).
Terstappen, G. C., Meyer, A. H., Bell, R. D. & Zhang, W. Strategies for delivering therapeutics across the blood–brain barrier. Nat. Rev. Drug Discov. 20, 362–383 (2021).
Janzer, R. C. & Raff, M. C. Astrocytes induce blood–brain barrier properties in endothelial cells. Nature 325, 253–257 (1987).
Abbott, N. J., Rönnbäck, L. & Hansson, E. Astrocyte–endothelial interactions at the blood-brain barrier. Nat. Rev. Neurosci. 7, 41–53 (2006).
Daneman, R., Zhou, L., Kebede, A. A. & Barres, B. A. Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature 468, 562–566 (2010).
Armulik, A. et al. Pericytes regulate the blood–brain barrier. Nature 468, 557–561 (2010).
da Fonseca, A. C. C. et al. The impact of microglial activation on blood–brain barrier in brain diseases. Front. Cell. Neurosci. 8, 362 (2014).
Archie, S. R., Shoyaib, Al,A. & Cucullo, L. Blood–brain barrier dysfunction in CNS disorders and putative therapeutic targets: an overview. Pharmaceutics 13, 1779 (2021).
Phoenix, T. N. et al. Medulloblastoma genotype dictates blood brain barrier phenotype. Cancer Cell 29, 508–522 (2016).
Cucullo, L. et al. Development of a humanized in vitro blood–brain barrier model to screen for brain penetration of antiepileptic drugs. Epilepsia 48, 505–516 (2007).
Lee, Y.-K., Uchida, H., Smith, H., Ito, A. & Sanchez, T. The isolation and molecular characterization of cerebral microvessels. Nat. Protoc. 14, 3059–3081 (2019).
Devraj, G. et al. HIF-1α is involved in blood–brain barrier dysfunction and paracellular migration of bacteria in pneumococcal meningitis. Acta Neuropathol. 140, 183–208 (2020).
Guerit, S. et al. Astrocyte-derived Wnt growth factors are required for endothelial blood-brain barrier maintenance. Prog. Neurobiol. 199, 101937 (2021).
Crouch, E. E. & Doetsch, F. FACS isolation of endothelial cells and pericytes from mouse brain microregions. Nat. Protoc. 13, 738–751 (2018).
Lyck, R. et al. Culture-induced changes in blood–brain barrier transcriptome: implications for amino-acid transporters in vivo. J. Cereb. Blood Flow. Metab. 29, 1491–1502 (2009).
Vanlandewijck, M. et al. A molecular atlas of cell types and zonation in the brain vasculature. Nature 554, 475–480 (2018).
Daneman, R. et al. The mouse blood–brain barrier transcriptome: a new resource for understanding the development and function of brain endothelial cells. PLoS ONE 5, e13741 (2010).
Zhang, Y. et al. An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J. Neurosci. 34, 11929–11947 (2014).
He, L. et al. Analysis of the brain mural cell transcriptome. Sci. Rep. 6, 35108 (2016).
Winkler, E. A. et al. A single-cell atlas of the normal and malformed human brain vasculature. Science 375, eabi7377 (2022).
Batiuk, M. Y. et al. An immunoaffinity-based method for isolating ultrapure adult astrocytes based on ATP1B2 targeting by the ACSA-2 antibody. J. Biol. Chem. 292, 8874–8891 (2017).
Kantzer, C. G. et al. Anti-ACSA-2 defines a novel monoclonal antibody for prospective isolation of living neonatal and adult astrocytes. Glia 65, 990–1004 (2017).
Wylot, B., Konarzewska, K., Bugajski, L., Piwocka, K. & Zawadzka, M. Isolation of vascular endothelial cells from intact and injured murine brain cortex-technical issues and pitfalls in FACS analysis of the nervous tissue. Cytom. A 87, 908–920 (2015).
Gurnik, S. et al. Angiopoietin-2-induced blood-brain barrier compromise and increased stroke size are rescued by VE-PTP-dependent restoration of Tie2 signaling. Acta Neuropathol. 131, 753–773 (2016).
Liebner, S. et al. Wnt/β-catenin signaling controls development of the blood–brain barrier. J. Cell Biol. 183, 409–417 (2008).
Bennett, M. L. et al. New tools for studying microglia in the mouse and human CNS. Proc. Natl Acad. Sci. USA 113, E1738–E1746 (2016).
Zhang, Y. et al. Purification and characterization of progenitor and mature human astrocytes reveals transcriptional and functional differences with mouse. Neuron 89, 37–53 (2016).
Foo, L. C. Purification of rat and mouse astrocytes by immunopanning. Cold Spring Harb. Protoc. 2013, 421–432 (2013).
Spitzer, D. et al. Profiling the neurovascular unit unveils detrimental effects of osteopontin on the blood–brain barrier in acute ischemic stroke. Acta Neuropathol. https://doi.org/10.1007/s00401-022-02452-1 (2022).
Srinivasan, K. et al. Untangling the brain’s neuroinflammatory and neurodegenerative transcriptional responses. Nat. Commun. 7, 11295 (2016).
Sundstrøm, T. et al. Automated tracking of nanoparticle-labeled melanoma cells improves the predictive power of a brain metastasis model. Cancer Res. 73, 2445–2456 (2013).
Daphu, I. et al. In vitro treatment of melanoma brain metastasis by simultaneously targeting the MAPK and PI3K signaling pathways. Int. J. Mol. Sci. 15, 8773–8794 (2014).
Di Tacchio, M. et al. Tumor vessel normalization, immunostimulatory reprogramming, and improved survival in glioblastoma with combined inhibition of PD-1, angiopoietin-2, and VEGF. Cancer Immunol. Res. 7, 1910–1927 (2019).
Richardson, G. M., Lannigan, J. & Macara, I. G. Does FACS perturb gene expression? Cytom. A 87, 166–175 (2015).
Grabert, K. et al. Microglial brain region-dependent diversity and selective regional sensitivities to aging. Nat. Neurosci. 19, 504–516 (2016).
Jurga, A. M., Paleczna, M. & Kuter, K. Z. Overview of general and discriminating markers of differential microglia phenotypes. Front. Cell. Neurosci. 14, 198 (2020).
Haage, V. et al. Comprehensive gene expression meta-analysis identifies signature genes that distinguish microglia from peripheral monocytes/macrophages in health and glioma. Acta Neuropathol. Commun. 7, 20 (2019).
Cahoy, J. D. et al. A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J. Neurosci. 28, 264–278 (2008).
Zhou, L., Sohet, F. & Daneman, R. Purification and culture of central nervous system endothelial cells. Cold Spring Harb. Protoc. 2014, 44–46 (2014).
Navone, S. E. et al. Isolation and expansion of human and mouse brain microvascular endothelial cells. Nat. Protoc. 8, 1680–1693 (2013).
Sheikh, B. N. et al. Systematic identification of cell–cell communication networks in the developing brain. iScience 21, 273–287 (2019).
Liu, L. & Shi, G.-P. CD31: beyond a marker for endothelial cells. Cardiovasc. Res. 94, 3–5 (2012).
Espina, V. et al. Laser-capture microdissection. Nat. Protoc. 1, 586–603 (2006).
Garrido-Gil, P., Fernandez-Rodríguez, P., Rodríguez-Pallares, J. & Labandeira-Garcia, J. L. Laser capture microdissection protocol for gene expression analysis in the brain. Histochem. Cell Biol. 148, 299–311 (2017).
Ståhl, P. L. et al. Visualization and analysis of gene expression in tissue sections by spatial transcriptomics. Science 353, 78–82 (2016).
Vickovic, S. et al. High-definition spatial transcriptomics for in situ tissue profiling. Nat. Methods 16, 987–990 (2019).
Brady, L. et al. Inter- and intra-tumor heterogeneity of metastatic prostate cancer determined by digital spatial gene expression profiling. Nat. Commun. 12, 1426 (2021).
Devraj, K. et al. GLUT-1 glucose transporters in the blood–brain barrier: differential phosphorylation. J. Neurosci. Res. 89, 1913–1925 (2011).
Devraj, K. et al. BACE-1 is expressed in the blood–brain barrier endothelium and is upregulated in a murine model of Alzheimer’s disease. J. Cerebr. Blood Flow Metab. 36, 1281–1294 (2016).
Song, H. W. et al. Transcriptomic comparison of human and mouse brain microvessels. Sci. Rep. 10, 12358 (2020).
Leisegang, M. S. et al. Long noncoding RNA MANTIS facilitates endothelial angiogenic function. Circulation 136, 65–79 (2017).
Devraj, K., Guerit, S., Macas, J. & Reiss, Y. An in vivo blood–brain barrier permeability assay in mice using fluorescently labeled tracers. JoVE 132, e57038–e57038 (2018).
Lex, A. & Gehlenborg, N. Sets and intersections. Nat. Methods 11, 779 (2014).
Lex, A., Gehlenborg, N., Strobelt, H., Vuillemot, R. & Pfister, H. UpSet: visualization of intersecting sets. IEEE Trans. Vis. Comput. Gr. 20, 1983–1992 (2014).
Dubinski, D. et al. Controversial roles for dexamethasone in glioblastoma - Opportunities for novel vascular targeting therapies. J. Cereb. Blood Flow. Metab. 39, 1460–1468 (2019).
Bernatz, S. et al. Impact of docetaxel on blood–brain barrier function and formation of breast cancer brain metastases. J. Exp. Clin. Cancer Res. 38, 434 (2019).
Acknowledgements
The authors acknowledge the contributions of B. Yalcin, J. Macas and C. Czupalla with the FACS compensation and troubleshooting of the sorter and for inputs regarding the gating strategy. The authors thank S. Momma and I. Kur for neuronal staining. The authors would like to also thank L. Hansen and N. Lohfink for assistance with mice handling. The authors acknowledge SFB 1039 for funding D.S. and SFB TR23 to Y.R., K.H.P. and S.L., and GO-IN fellowship (291776) for funding Sy.G. and M.D.T., LI 911/5-1 to S.L., EU JUSTBRAIN consortium and Sphingonet consortium of LeducQ foundation for funding K.D. The authors acknowledge LOEWE CePTER consortium for funding Y.R., K.H.P., S.L. and K.D. The authors acknowledge the Edinger Institute for funding all the consumables and softwares with respect to FACS sorting and analysis.
Author information
Authors and Affiliations
Contributions
D.S., Sy.G., T.P. and K.D. performed tissue dissociation and FACS staining of WT healthy mice and human specimens; J.Z., X.J. and K.S. performed intracardial tumor cell injections and metastasis model characterization by immunohistochemistry; D.S., J.Z. and X.J. performed tissue dissociation and FACS staining for mouse metastasis model; Sy.G. and K.D. performed FACS operation and sorting; M.D.T., Sy.G., and K.D. analyzed and designed the FACS gating strategy with inputs from Y.R. and S.L.; D.S. and M.D.T. performed FACS analysis and prepared FACS plots; D.S., Sy.G., T.P. and M.I.K. performed qPCR analysis; St.G. performed the transcriptomic analysis. Sy.G. created the figures and performed statistics with assistance from K.D.; F.T. established the mouse melanoma model; T.M.F. operated the patients and performed the resection of the biopsies; K.F., K.H.P. and P.N.H. performed dissection and neuropathological analysis of human tissue; Sy.G., Y.R., S.L., M.D.T. and K.D. developed and improved the enzyme combinations and antigen selection. D.S., Sy.G. and K.D. wrote the manuscript with inputs from all the authors. K.D. and Sy.G. designed the overall protocol and also supervised the study.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Peer review
Peer review information
Nature Protocols thanks Eduardo Candelario-Jalil, Elizabeth Crouch and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Related links
Key references using this protocol
Spitzer, D. et al. Acta Neuropathol. 144, 305–337 (2022): https://doi.org/10.1007/s00401-022-02452-1
Guérit, S. et al. Prog. Neurobiol. 199, 101937 (2021): https://doi.org/10.1016/j.pneurobio.2020.101937
Devraj, G. et al. Acta Neuropathol. 140, 183–208 (2020): https://doi.org/10.1007/s00401-020-02174-2
Extended data
Extended Data Fig. 1 Assessment of papain concentration in Digestion Mix 1 of the EPAM-ia method on cell yield and viability.
a) Gating strategy for the isolation of endothelial cells, pericytes (mural cells), astrocytes, and microglia from mouse cerebrum digested according to the EPAM-ia protocol with 0.1% of papain in the Digestion Mix 1, representative experiment of n=3. Initial FSC/SSC dot plot show 1,000,000 events. Percentages refer to the proportion of cells in the previous parental gate. (b) Normalized cell events of the four major NVU cell types isolated using different papain concentration in the Digestion Mix 1 (with 0.025%, n=4; 0.05% n=5; 0.1% n=3;). (c) Normalized number of dead cells using different concentrations of papain in the Digestion Mix 1.
Extended Data Fig. 2 Assessment of alternative kit-based Digestion Mix 1 and debris removal solution on cell yield, viability, and purity of the isolated NVU cells.
(a) Schematic indicating with an asterisk the two steps during the cell suspension preparation for which kit based solutions are used. (b) Identical gating strategy as in the fully defined EPAM-ia method is applied to obtained microglia, astrocytes, endothelial cells and pericytes (mural cells) from the same brain tissue sample with the kit based Digestion mix 1 and debris removal steps. The FSC/SSC plot shows 1,000,000 events. Percentages refer to the proportion of cells in the previous parental gate. (c) Normalized cell events of endothelial cells (EC), pericytes (PC), astrocytes (AC) and microglia (MG) isolated by flow cytometry after tissue dissociation using commercially available solutions for the Digestion Mix 1 and the debris removal (n=5). (d) Normalized number of dead cells. (e-h) Purity of kit-based and EPAM-ia method sorted cells is assessed by qPCR targeting cell type-specific markers of endothelial cells (e, Cdh5, Slca1a1), pericytes (f, Kcnj8), astrocytes (g, Aqp4, Slc1a3), and microglia (h, Tmem119). If no amplification was detected, the ∆Ct value is set at 15 by default (n=4). One way ANOVA followed by Dunnett’s multiple comparison test. *, †, § and $ indicate comparison to EC, PC, AC and MG respectively. *p≤0.05, **p≤0.01, ***p≤0.001, ****p≤0.0001 and ns: not significant. Panels a,e–h adapted with permission from ref. 31, Springer.
Extended Data Fig. 3 Enrichment analysis of the isolated NVU cell types and the all negative population.
(a) Detailed transcripts reads for representative cell type markers genes of endothelial cells (EC), pericytes (PC), astrocytes (AC) and microglia (MG) in healthy single brain (n=1) or stroke contralateral hemisphere tissue (n=4, 3-4 mice/preparation). (b) Heatmap representing log2 expression of selected choroid plexus and neuronal cell-specific marker genes in endothelial cells, pericytes, astrocytes, microglia and all negative (AN) population isolated from a single mouse cerebrum (n=1). (c) FACS plots showing isolation of NeuN positive neurons by EPAM-ia method. Cells isolated by EPAM-ia method were preselected with ACSA2 magnetic beads followed by brief fixation (0.4% PFA) and permeabilization (0.1% Triton X-100) before immunostaining (n=2). Percentages refer to the proportion of cells in the previous parent gate. First SSC/FSC gate shows 200,000 events.
Supplementary information
Supplementary Information
Supplementary Figs. 1–8.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Spitzer, D., Khel, M.I., Pütz, T. et al. A flow cytometry-based protocol for syngenic isolation of neurovascular unit cells from mouse and human tissues. Nat Protoc 18, 1510–1542 (2023). https://doi.org/10.1038/s41596-023-00805-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41596-023-00805-y
This article is cited by
-
Profiling human brain vascular cells using single-cell transcriptomics and organoids
Nature Protocols (2024)
-
Bioinformatics for wet-lab scientists: practical application in sequencing analysis
BMC Genomics (2023)
-
Effects of repeated sleep deprivation on brain pericytes in mice
Scientific Reports (2023)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.